Literature DB >> 7961101

Effects of cigarette smoke on N-nitrosobis(2-oxopropyl)amine-induced pancreatic and respiratory tumorigenesis in hamsters.

A Nishikawa1, F Furukawa, T Imazawa, H Yoshimura, S Ikezaki, Y Hayashi, M Takahashi.   

Abstract

Influences of cigarette smoke on N-nitrosobis(2-oxopropyl)amine (BOP)-induced pancreatic duct and respiratory tract tumorigenesis were investigated using a hamster two-stage carcinogenesis model. Male 5-week-old hamsters were divided into 5 groups. Group 1 was s.c. injected with BOP at a dose of 10 mg/kg once a week for 3 weeks as an initiation treatment together with cigarette smoke exposure over the same 4-week period. Group 2 was exposed to cigarette smoke for 26 weeks after the BOP-initiation. Groups 3 and 4 were respectively given the BOP-initiation alone and the 26-week cigarette smoke exposure without initiation. Group 5 served as a sham-smoked negative control. The experiment was terminated 30 weeks after the first BOP injection. The incidence of pancreatic adenocarcinomas was significantly decreased in Group 1 as compared to the Group 3 value (P < 0.01) while the Group 2 value did not show any change. In contrast, the incidence of laryngeal and tracheal proliferative lesions (hyperplasias and papillomas) was significantly increased in Group 2 over Group 3 (P < 0.01). The incidence of pulmonary hyperplasias was also increased in Group 2 over Group 3 (P < 0.05), although that of pulmonary adenomas or adenocarcinomas was decreased in Group 2 as compared to the Group 3 value (P < 0.01). Cigarette smoke exposure in the BOP-initiation phase (Group 1) did not affect the development of respiratory proliferative lesions. No animals in Groups 4 and 5 developed any tumors in the pancreas or respiratory tract. Our results thus indicate that cigarette smoke exposure inhibits pancreatic carcinogenesis when given in the initiation phase, whereas it modulates (enhances or suppresses) the development of proliferative lesions in the respiratory tract if applied during the promotion stage to hamsters pretreated with BOP.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7961101      PMCID: PMC5919357          DOI: 10.1111/j.1349-7006.1994.tb02897.x

Source DB:  PubMed          Journal:  Jpn J Cancer Res        ISSN: 0910-5050


  17 in total

1.  Role of the alveolar type II cell in the development and progression of pulmonary tumors induced by 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in the A/J mouse.

Authors:  S A Belinsky; T R Devereux; J F Foley; R R Maronpot; M W Anderson
Journal:  Cancer Res       Date:  1992-06-01       Impact factor: 12.701

2.  Effects of various prostaglandin synthesis inhibitors on pancreatic carcinogenesis in hamsters after initiation with N-nitrosobis(2-oxopropyl)amine.

Authors:  M Takahashi; F Furukawa; K Toyoda; H Sato; R Hasegawa; K Imaida; Y Hayashi
Journal:  Carcinogenesis       Date:  1990-03       Impact factor: 4.944

3.  Methylation of hamster DNA by the carcinogen N-nitroso-bis (2-oxopropyl)amine.

Authors:  T A Lawson; R Gingell; D Nagel; L A Hines; A Ross
Journal:  Cancer Lett       Date:  1981-01       Impact factor: 8.679

4.  Induction of respiratory tract tumors in Syrian golden hamsters by a single dose of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) and the effect of smoke inhalation.

Authors:  S S Hecht; J D Adams; S Numoto; D Hoffmann
Journal:  Carcinogenesis       Date:  1983-10       Impact factor: 4.944

5.  Induction of lung and exocrine pancreas tumors in F344 rats by tobacco-specific and Areca-derived N-nitrosamines.

Authors:  A Rivenson; D Hoffmann; B Prokopczyk; S Amin; S S Hecht
Journal:  Cancer Res       Date:  1988-12-01       Impact factor: 12.701

6.  Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.

Authors:  Y Mori; H Yamazaki; K Toyoshi; A Denda; Y Konishi
Journal:  Carcinogenesis       Date:  1986-03       Impact factor: 4.944

7.  Improvement of pancreatic cancer model by modified treatment with N-nitroso-bis (2-oxopropyl) amine.

Authors:  P Pour; J Althoff; F W Krüger; U Mohr
Journal:  Cancer Lett       Date:  1977-03       Impact factor: 8.679

8.  Metabolic alterations produced by cigarette smoke in rat lung and liver, and their modulation by oral N-acetylcysteine.

Authors:  M Bagnasco; C Bennicelli; A Camoirano; R M Balansky; S De Flora
Journal:  Mutagenesis       Date:  1992-07       Impact factor: 3.000

9.  A potent pancreatic carcinogen in Syrian hamsters: N-nitrosobis(2-oxopropyl)amine.

Authors:  P Pour; J Althoff; F W Krüger; U Mohr
Journal:  J Natl Cancer Inst       Date:  1977-05       Impact factor: 13.506

10.  Carcinogen metabolism in human lung tissues and the effect of tobacco smoking: results from a case--control multicenter study on lung cancer patients.

Authors:  H Bartsch; S Petruzzelli; S De Flora; E Hietanen; A M Camus; M Castegnaro; K Alexandrov; M Rojas; R Saracci; C Giuntini
Journal:  Environ Health Perspect       Date:  1992-11       Impact factor: 9.031

View more
  1 in total

1.  Mechanistic insights into chemopreventive effects of phenethyl isothiocyanate in N-nitrosobis(2-oxopropyl)amine-treated hamsters.

Authors:  A Nishikawa; I S Lee; C Uneyama; F Furukawa; H C Kim; K Kasahara; N Huh; M Takahashi
Journal:  Jpn J Cancer Res       Date:  1997-12
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.